5-Methylmethiopropamine
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C9H15NS |
| Molar mass | 169.29 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-Methylmethiopropamine (5-MMPA, mephedrene) is a stimulant drug which is a ring-substituted derivative of methiopropamine. It is not a substituted cathinone derivative like mephedrone, as it lacks a ketone group at the β position of the aliphatic side chain, but instead more closely resembles substituted amphetamines. It has been sold as a designer drug, first being identified in Germany in June 2020.[1][2][3]
See also
[edit]References
[edit]- ^ EU Early Warning System Situation Report. Situation report 2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (Report). 10 August 2020.
- ^ "Info" (PDF). www.aekwien.at. Retrieved 2021-05-13.
- ^ New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020